Calidi Biotherapeutics Inc Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| GEODE CAPITAL MANAGEMENT, LLC | 08/12/2026 | 114.55 K | $19.47 K | 81.77% | 0.51% |
| HIGHTOWER ADVISORS, LLC | 08/05/2026 | 83.52 K | $14.20 K | 0.00% | 0.37% |
| JANE STREET GROUP, LLC | 08/14/2026 | 54.27 K | $9.23 K | 55.95% | 0.24% |
| INDEPENDENT ADVISOR ALLIANCE | 08/12/2026 | 45.00 K | $7.65 K | 100.00% | 0.20% |
| RS CRUM INC. | 08/10/2026 | 43.24 K | $7.35 K | 7.41% | 0.19% |
| SRS CAPITAL ADVISORS, INC. | 08/10/2026 | 37.35 K | $6.35 K | 0.00% | 0.16% |
| PRIVATE ADVISOR GROUP, LLC | 07/27/2026 | 30.00 K | $5.10 K | 100.00% | 0.13% |
| VANGUARD CAPITAL MANAGEMENT LLC | 08/13/2026 | 25.51 K | $4.34 K | 0.00% | 0.11% |
| BELPOINTE ASSET MANAGEMENT LLC | 07/31/2026 | 19.92 K | $3.39 K | 0.00% | 0.09% |
| NORTHERN TRUST CORP | 08/13/2026 | 17.76 K | $3.02 K | 0.00% | 0.08% |
| MORGAN STANLEY | 08/13/2026 | 13.24 K | $2.25 K | 39.90% | 0.06% |
| RFG ADVISORY, LLC | 07/15/2026 | 12.00 K | $2.04 K | 100.00% | 0.05% |
| FARTHER FINANCE ADVISORS, LLC | 07/17/2026 | 10.00 K | $1.70 K | 0.00% | 0.04% |
| UBS GROUP AG | 08/13/2026 | 7.88 K | $1.34 K | 100.00% | 0.03% |
| CITIGROUP INC | 08/03/2026 | 4.59 K | $781 | 32,714.29% | 0.02% |
| ADVISOR GROUP HOLDINGS, INC. | 08/14/2026 | 2.65 K | $450 | 25.83% | 0.01% |
| TOWER RESEARCH CAPITAL LLC (TRC) | 08/11/2026 | 1.40 K | $237 | 0.00% | 0.01% |
| HIGHBRIDGE CAPITAL MANAGEMENT LLC | 08/14/2026 | 1.04 K | $177 | 0.00% | 0.00% |
| FINEPOINT CAPITAL LP | 08/13/2026 | 1.04 K | $177 | 0.00% | 0.00% |
| SBI SECURITIES CO., LTD. | 07/23/2026 | 375 | $64 | 226.09% | 0.00% |
| TRADEWINDS CAPITAL MANAGEMENT, LLC | 07/24/2026 | 101 | $18 | 0.00% | 0.00% |
| REYES FINANCIAL ARCHITECTURE, INC. | 07/17/2026 | 100 | $17 | 0.00% | 0.00% |
| MERCER GLOBAL ADVISORS INC /ADV | 08/11/2026 | 50 | $9 | 100.00% | 0.00% |
| EVERMAY WEALTH MANAGEMENT LLC | 07/27/2026 | 1 | $1 | 0.00% | 0.00% |
| JPMORGAN CHASE & CO | 08/12/2026 | 0 | $0 | -100.00% | 0.00% |
| FMR LLC | 08/13/2026 | 0 | $0 | -100.00% | 0.00% |
| VANGUARD FIDUCIARY TRUST CO | 08/13/2026 | 0 | $0 | -100.00% | 0.00% |
| APOLLO MANAGEMENT HOLDINGS, L.P. | 08/14/2026 | 0 | $0 | -100.00% | 0.00% |
| HRT FINANCIAL LP | 08/14/2026 | 0 | $0 | -100.00% | 0.00% |
| VIRTU FINANCIAL LLC | 08/13/2026 | 0 | $0 | -100.00% | 0.00% |
| SABBY MANAGEMENT, LLC | 08/14/2026 | 0 | $0 | -100.00% | 0.00% |
| WARBERG ASSET MANAGEMENT LLC | 08/11/2026 | 0 | $0 | -100.00% | 0.00% |
| ARMISTICE CAPITAL, LLC | 08/14/2026 | 0 | $0 | -100.00% | 0.00% |
| CVA FAMILY OFFICE, LLC | 08/07/2026 | 0 | $0 | -100.00% | 0.00% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Calidi Biotherapeutics Inc institutional Ownership - FAQ's
During the previous two years, 37 institutional investors and hedge funds held shares of Calidi Biotherapeutics Inc. The most heavily invested institutionals were:
GEODE CAPITAL MANAGEMENT, LLC: 114,550
HighTower Advisors, LLC: 83,523
JANE STREET GROUP, LLC: 54,274
Independent Advisor Alliance: 45,000
RS CRUM INC.: 43,239
SRS Capital Advisors, Inc.: 37,345
2.32% of Calidi Biotherapeutics Inc stock is owned by institutional investors.
Institutional investors have bought a total of 572.91 K shares in the last 24 months. This purchase volume represents approximately $211.98 K in transactions.